Giant Cell Arteritis

Treatment failure in giant cell arteritis
Sebastian H Unizony, Min Bao, Jian Han, Yves Luder, Andrey Pavlov, John H Stone

Annals of the Rheumatic Diseases May 2021, annrheumdis-2021-220347; DOI: 10.1136/annrheumdis-2021-220347
Ultrasound halo sign as a potential monitoring tool for patients with giant cell arteritis: a prospective analysis
Cristina Ponte, Sara Monti, Carlo Alberto Scirè, Paolo Delvino, Nikita Khmelinskii, Alessandra Milanesi, Vítor Teixeira, Fabio Brandolino, Fernando Saraiva, Carlomaurizio Montecucco, João Eurico Fonseca, Wolfgang A Schmidt, Raashid Ahmed Luqmani

Annals of the Rheumatic Diseases Jul 2021, annrheumdis-2021-220306; DOI: 10.1136/annrheumdis-2021-220306
Response to ‘Correspondence on ‘Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: a monocentric survey’’ by Montero et al
Alessandro Tomelleri, Lorenzo Dagna, Corrado Campochiaro

Annals of the Rheumatic Diseases Jul 2021, annrheumdis-2021-220959; DOI: 10.1136/annrheumdis-2021-220959
Correspondence on ‘Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey’
Fernando Montero, Isabel Castrejón, Julia Martínez-Barrio, Juan Carlos Nieto-González, Javier Rivera, José María Álvaro-Gracia, Juan Molina Collada

Annals of the Rheumatic Diseases Jul 2021, annrheumdis-2021-220941; DOI: 10.1136/annrheumdis-2021-220941
Impact of the COVID-19 lockdown on the management and control of patients with GCA
Roman Praliaud, Helene Greigert, Maxime Samson, Marianne Zeller, Mathieu Boulin, Philip Bielefeld, André Ramon, Yves Cottin, Bernard Bonnotte

Annals of the Rheumatic Diseases Jun 2021, 80 (6) e102; DOI: 10.1136/annrheumdis-2020-218360
Response to: ‘Increased rather than decreased incidence of giant-cell arteritis during the COVID-19 pandemic’ by Lecler et al
Sara Monti, Carlomaurizio Montecucco

Annals of the Rheumatic Diseases Jun 2021, 80 (6) e90; DOI: 10.1136/annrheumdis-2020-218634
Increased rather than decreased incidence of giant-cell arteritis during the COVID-19 pandemic
Augustin Lecler, Delphine Villeneuve, Catherine Vignal, Thomas Sené

Annals of the Rheumatic Diseases Jun 2021, 80 (6) e89; DOI: 10.1136/annrheumdis-2020-218343
Correspondence on ‘Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia’
Gerasimos Evangelatos, George E Fragoulis, Alexios Iliopoulos

Annals of the Rheumatic Diseases Dec 2020, annrheumdis-2020-219463; DOI: 10.1136/annrheumdis-2020-219463
Response to: ‘Correspondence on ‘Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia’’ by Evangelatos et al
Kornelis SM van der Geest, Bhaskar Dasgupta

Annals of the Rheumatic Diseases Dec 2020, annrheumdis-2020-219477; DOI: 10.1136/annrheumdis-2020-219477
Impact of delayed diagnoses at the time of COVID-19: increased rate of preventable bilateral blindness in giant cell arteritis
Sara Monti, Paolo Delvino, Elisa Bellis, Alessandra Milanesi, Fabio Brandolino, Carlomaurizio Montecucco

Annals of the Rheumatic Diseases Dec 2020, 79 (12) 1658-1659; DOI: 10.1136/annrheumdis-2020-217915

Main menu

Giant Cell Arteritis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Giant Cell Arteritis

Pages